Charles Elliott Sigal

CIK: 0001661908

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

VIR

Vir Biotechnology, Inc.

Director

ALNY

ALNYLAM PHARMACEUTICALS, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

VIR
Vir Biotechnology, Inc.
May 27, 2026
Award(A)
Direct
8K shares-
ALNY
ALNYLAM PHARMACEUTICALS, INC.
May 20, 2026
Award(A)
Direct
671 shares-
VIR
Vir Biotechnology, Inc.
May 30, 2025
Award(A)
Direct
8K shares-
ALNY
ALNYLAM PHARMACEUTICALS, INC.
May 8, 2025
Award(A)
Direct
775 shares-

		Type	Shares	Price		Ownership
May 27, 2026	VIR Vir Biotechnology, Inc.	Award(A)	8,000	-	$0	Direct
May 20, 2026	ALNY ALNYLAM PHARMACEUTICALS, INC.	Award(A)	671	-	$0	Direct
May 30, 2025	VIR Vir Biotechnology, Inc.	Award(A)	8,000	-	-	Direct
May 8, 2025	ALNY ALNYLAM PHARMACEUTICALS, INC.	Award(A)	775	-	-	Direct

1-4 of 4 transactions

About Sigal Charles Elliott

Sigal Charles Elliott (SEC CIK 0001661908) files insider reports with the SEC as Director of Vir Biotechnology, Inc. (VIR) and Director of ALNYLAM PHARMACEUTICALS, INC. (ALNY).

Signal8 holds 4 ownership filings by Sigal Charles Elliott, all Form 4s, filed between May 12, 2025 and May 28, 2026. Those filings report 4 transactions, from May 8, 2025 to May 27, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Sigal Charles Elliott's filings is in CAMBRIDGE, MA.

Recent filings by Sigal Charles Elliott

May 27, 2026: Grant or award of VIR shares (Form 4, code A).
May 20, 2026: Grant or award of ALNY shares (Form 4, code A).
May 30, 2025: Grant or award of VIR shares (Form 4, code A).
May 8, 2025: Grant or award of ALNY shares (Form 4, code A).

Other insiders filing for Vir Biotechnology, Inc. (VIR)

Topalian Suzanne Louise, Director
Sawaf Aziz, EVP, Chief Financial Officer
MORE ROBERT J, Director
Coughlin Timothy, Director
Napolitano Janet, Director
Sabatini Brent, SVP, Chief Accounting Officer

How to read Form 4 transaction codes